Hello, everyone, and nice to see you again. We hope the weekend was relaxing and invigorating. Now, though, the time has come to resume the routine of meetings and deadlines. To cope, we are quaffing our usual cup of stimulation. Please join us, or grab a bottle of water, if you prefer; another hot day is expected, after all. Meanwhile, here is the news of the world - no, not the sort associated with Rupert Murdoch, just a few useful headlines. Hope your day goes well and stay in touch...
6-Year-Old Son Of Medicis Pharma CEO Dies After Accident (Washington Post)
Forest Reports Positive Results For Antidepressant (Associated Press)
Novartis Has No Need To Buy Intercell (Reuters)
Lupin May Sell Indian Pharmaceutical Unit (Bloomberg News)
Teva May Relocate Branded Products To US (Yediot Aharanot)
Transcept Slashes Jobs After Insomnia Pill Is Rejected (Pharma Times)
AstraZeneca Braces For FDA Moves On Heart & Diabetes Meds (The Telegraph)
PPD May Be For Sale (Outsourcing Pharma)
Elder Pharma Plans To Add 1,000 Sales Jobs In India (The Economic Times)
Asthma Pill Threatens Inhalers In 'Pragmatic Trial' (InPharma Technologist)
Ranbaxy Refuses To Pay Rite Aid Legal Costs (The Economic Times)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sweat pix thx to jessica rabbit on flickr
1 Comment
Given the stress that Fore appears to be under, good news about their antidepressant seems ... Appropriate?